FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

Zepbound (tirzepatide) is only available on prescription ... Additionally, it is important to note that the FDA does not approve compounded versions of GLP-1 drugs, which some telehealth companies ...

Recently, the FDA ruled that the shortage of the weight loss drug tirzepatide is resolved. This means that manufacturers of compound versions of the drug sold by the likes of Hims & Hers have ...

Ashwin K. Chetty, from the Yale University School of Medicine in New Haven, Connecticut, and colleagues examined advertising practices of websites selling compounded GLP-1 RAs, including semaglutide, ...

Tirzepatide was removed from the shortages list a few weeks ago, leading to restrictions on the sale of compounded versions. However, the FDA has launched a review to check if the shortages have ...

Leerink Partners analyst David Risinger maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on January 24 and set a price target of $950.00. David Risinger has given his Buy rating ...

Add Me on the Pixel 9 lets you combine multiple pics to add subjects to a photo. Google started work on the idea back in 2022, three years before its debut. Add Me’s creation ultimately required ...

Eli Lilly's tirzepatide has been shown to significantly cut cardiovascular risks in patients with obesity and a form of heart failure with few treatment options, in another big win for the GLP-1 ...

If you've been scrolling through TikTok recently, you might have come across the "winter arc" trend — a sort of fresh take on the "new year, new me" mindset. The idea behind this social media ...